Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Zhonghua Yan Ke Za Zhi ; 49(6): 526-30, 2013 Jun.
Article in Chinese | MEDLINE | ID: mdl-24119966

ABSTRACT

OBJECTIVE: To determine the characteristics of optic nerve meningiomas in medical imageology (including CT and MRI), histopathology and immunohistochemical expression of Vimentin, CK, S-100, EMA in tumor cells. METHODS: This was a retrospective study on a serial of clinical cases. Forty-eight cases were collected from the past 21 years at the Department of Ophthalmology, West China Hospital, Sichuan University. All the cases underwent surgery and were confirmed as optic nerve meningiomas by histopathological test, including paraffin imbedded sectioning and HE staining. In addition, all the cases had medical records on CT and 17 cases had MIR scan. Immunohistochemical staining for VIMENTIN, CK, S-100, EMA was performed in the 21 cases. RESULTS: Characteristics of the CT scan include that, in 39 cases, among them 26 cases the tumors filled in the orbit especially at the orbital apex, which led to the disappearance of the black triangle. Three cases showed enlargement and calcification of optic nerve and therefore train track sign was seen. Three cases showed that the masses of optic nerve were close to the globe and another three cases showed that the masses were located in the peripheral orbit. Thirteen of 17 cases MRI disclosed the big orbital tumors and 5 cases could better show tumor extension to optic cross or intracranium. Histopathological tests demonstrated meningothelial or syncytial type in 39 cases, transitional or mixing type in 8 cases, fiber or fibroblast type in 3 cases and vascular type in 2 cases. Immunohistochemistry study verified the positive staining rate of VIMENTIN as 90.5%(21 cases), EMA 66.7%(15 cases), CK 42.8%(9 cases) and S-100 23.8%(5 cases), respectively. CONCLUSIONS: Characteristics of CT and MRI include enlargement and tumor-like expansion of optic nerve. Most of the tumors reach to orbital apex and show uneven density. Calcification may occur in the tumor. The main pathological type of the tumors is meningothelial. Positive immunohistochemiscal staining for VIMENTIN and EMA may be helpful in diagnosis.


Subject(s)
Meningeal Neoplasms/pathology , Meningioma/pathology , Optic Nerve Neoplasms/pathology , Orbital Neoplasms/pathology , Adolescent , Adult , Aged , Child , Female , Humans , Immunohistochemistry , Magnetic Resonance Imaging , Male , Meningeal Neoplasms/diagnostic imaging , Meningioma/diagnostic imaging , Middle Aged , Optic Nerve Neoplasms/diagnostic imaging , Orbital Neoplasms/diagnostic imaging , Retrospective Studies , Tomography, X-Ray Computed , Young Adult
2.
Biomed Environ Sci ; 17(2): 153-64, 2004 Jun.
Article in English | MEDLINE | ID: mdl-15386941

ABSTRACT

OBJECTIVE: To investigate the anti-HIV effects of ampelopsin and its interaction with HIV-1 coreceptor CXCR4. METHODS: Through anti-virus experiments in vitro, the inhibitory effect of ampelopsin on HIV-1 infection was verified. Chemotaxis assay was performed to show the ability to induce PBMCs migration by ampelopsin, RANTES and SDF-1alpha. Fluorescence labelling monoclonal antibody was utilized to observe the interaction of ampelopsin and CXCR4. Mice immunosuppressant model was also established to detail the role ampelopsin played in regulating cellular immunological functions. RESULTS: Ampelopsin could protect sensitive cells against HIV-1 infection and dramatically reduce HIV-1 antigen P24 expression. HIV-1SF33 attaching to MT-4 cells was interfered by ampelopsin, and the EC50 was 0.175 mg/mL for cellular protection and 0.024 mg/mL for P24 inhibition. At co-cultivating phase, EC50 was 0.229 mg/mL and 0.197 mg/mL respectively. Furthermore, the EC50 was 0.179 mg/mL and 0.348 mg/mL in acute infection. Human PBMCs migration was induced after being challenged with ampelopsin or chemokines, and synergistic action was observed during co-treatment. Ampelopsin alone resulted in maximal chemotaxis at 1 mg/mL. HIV-1 co-receptor CXCR4 on the surface of PBMCs was decreased by internalization, which indicated the effect of ampelopsin on CXCR4. About 70% CXCR4 was reduced by ampelopsin at 1 mg/mL. Ampelopsin also augmented cellular immunological functions in immunosuppressive mice. CONCLUSION: Ampelopsin displays a strong inhibitive role during HIV-1 absorption, incubation and acute infection. These results are coincident with its immune enhancement.


Subject(s)
Anti-HIV Agents/pharmacology , Flavonoids/pharmacology , HIV Infections/virology , HIV-1/drug effects , HIV-1/pathogenicity , Leukocytes, Mononuclear/drug effects , Receptors, CXCR4/drug effects , Ampelopsis/chemistry , Animals , Cell Line , Chemokine CCL5/pharmacology , Chemokine CXCL12 , Chemokines, CXC/pharmacology , Chemotaxis, Leukocyte , Down-Regulation , Drugs, Chinese Herbal , Flavonoids/economics , Flavonoids/isolation & purification , HIV-1/metabolism , Humans , Interleukin-2/biosynthesis , Mice , Mice, Inbred BALB C , Models, Animal , Plant Roots/chemistry , Receptors, CXCR4/antagonists & inhibitors , Spleen/immunology , T-Lymphocytes/immunology
SELECTION OF CITATIONS
SEARCH DETAIL
...